ClinicalTrials.Veeva

Menu
H

Hospital Evangelico De Cachoeiro de Itapemirim | Centro de Pesquisas Clinicas em Oncologia

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Pembrolizumab
Nivolumab
5-Fluorouracil
Binimetinib
Irinotecan
Tislelizumab
Bemarituzumab
MEDI4736
Cetuximab
Encorafenib

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 5 total trials

A Study of Ociperlimab With Tislelizumab Compared to Pembrolizumab in Participants With Untreated Lung Cancer

The purpose of this study is to evaluate the efficacy and safety of ociperlimab + tislelizumab compared with that of pembrolizumab in adults with PD-...

Active, not recruiting
Non-small Cell Lung Cancer
NSCLC
Drug: Placebo
Drug: Tislelizumab

The main objective of Part 1 is to evaluate the safety and tolerability of bemarituzumab plus 5-fluorouracil, leucovorin, and oxaliplatin (mFOLFOX6)...

Enrolling
Gastric Cancer
Gastroesophageal Junction Adenocarcinoma
Other: Placebo
Drug: Nivolumab

The primary objective of this study is to compare the effect of zimberelimab (ZIM) and domvanalimab (DOM) in combination with chemotherapy relative t...

Enrolling
Non-small Cell Lung Cancer
Drug: Domvanalimab
Drug: Nab-paclitaxel

Trial sponsors

Amgen logo
BeiGene logo
Gilead Sciences logo
Pfizer logo
C

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems